Literature DB >> 10511357

Correlation between maternal thyroid function tests and endothelin in preeclampsia-eclampsia.

M Başbuğ1, E Aygen, M Tayyar, A Tutuş, E Kaya, O Oktem.   

Abstract

OBJECTIVE: To investigate the relationship between results of maternal thyroid function tests and endothelin levels in preeclamptic or eclamptic women.
METHODS: Thyroid hormones, TSH, and endothelin were measured in plasma or serum from 37 proteinuric, preeclamptic or eclamptic women and 20 normotensive, nonlaboring, pregnant women. Subjects were subdivided into four groups according to hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome and birth weights of infants with respect to gestational age.
RESULTS: A significant decrease in concentrations of total thyroxine (T4) (13.76+/-1.84 microg/dL versus 10.00+/-1.48 microg/dL, P < .05), total triiodothyronine (T3) (180.58+/-30.84 ng/dL versus 141.16+/-27.31 ng/dL, P < .01), free T4 (1.45+/-0.27 ng/dL versus 1.10+/-0.21 ng/dL, P < .01) and free T3 (3.32+/-0.56 pg/mL versus 2.41+/-0.60 pg/mL, P < .01) and a significant increase in TSH (1.55+/-0.89 microIU/mL versus 2.96 +/-1.07 microIU/mL, P < .05) and endothelin (2.31+/-0.61 pg/mL versus 6.11+/-1.41 pg/mL, P < .001) levels were observed in the preeclamptic-eclamptic group compared with the normotensive group. Also, women without HELLP syndrome and without small-for-gestational-age infants had elevated levels of thyroid hormones and decreased levels of TSH and endothelin compared with other subgroups, but stastical significance was reached only in total T4 (P < .05), TSH (P < .05), and endothelin (P < .001). Birth weights of infants born to preeclamptic or eclamptic women correlated positively with total T4 (P < .01) and total T3 (P < .01) and negatively with TSH (P < .01) levels. A more significant negative correlation was found in preeclamptic-eclamptics (P < .001) between birth weight and endothelin levels than in control subjects (P < .05). Endothelin levels in preeclamptic or eclamptic women correlated negatively with total T4 (P < .01), total T3 (P < .05), free T4 (P < .05), and free T3 (P < .05) and positively with TSH levels (P < .01) compared with control subjects.
CONCLUSION: Moderate decreases in thyroid hormones with concomitant increases in TSH levels in maternal serum correlated with severity of preeclampsia or eclampsia and high levels of endothelin. Changes in results of thyroid function tests induced by preeclampsia or eclampsia might be consequences of the dysfunction in the hypothalamic-pituitary-thyroid axis, secondary to the disease itself.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511357

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Thyroid hormones in pregnancy and preeclampsia.

Authors:  Divya Sardana; Smiti Nanda; Simmi Kharb
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

2.  Effect of Preeclampsia on Ultrastructure of Thyroid Gland, Hepatic Type 1 Iodothyronine Deiodinase, and Thyroid Hormone Levels in Rats.

Authors:  Yunlu Liu; Zhuping Xu; Yanqin Li; Wenyan Jiang; Ming Lan; Xiaojuan Xie; Yang Wang
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

3.  Association of thyroid function test abnormalities with preeclampsia: a systematic review and meta-analysis.

Authors:  Mahboubeh Hajifoghaha; Saeed Hosseini Teshnizi; Sedighe Forouhari; Mohammad Hossein Dabbaghmanesh
Journal:  BMC Endocr Disord       Date:  2022-09-26       Impact factor: 3.263

4.  Correlation of thyroid functions with severity and outcome of pregnancy.

Authors:  S Kharb; D Sardana; S Nanda
Journal:  Ann Med Health Sci Res       Date:  2013-01

5.  Comparison of serum levels of Tri-iodothyronine (T3), Thyroxine (T4), and Thyroid-Stimulating Hormone (TSH) in preeclampsia and normal pregnancy.

Authors:  Nayereh Khadem; Hossein Ayatollahi; Fatemeh Vahid Roodsari; Sedigheh Ayati; Ehsan Dalili; Masoud Shahabian; Taraneh Mohajeri; Mohamad Taghi Shakeri
Journal:  Iran J Reprod Med       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.